Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) EBT Margin (2017 - 2025)

Historic EBT Margin for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to 1002.65%.

  • Catheter Precision's EBT Margin rose 32890100.0% to 1002.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 2182.19%, marking a year-over-year increase of 7461300.0%. This contributed to the annual value of 3214.76% for FY2024, which is 127517500.0% up from last year.
  • As of Q3 2025, Catheter Precision's EBT Margin stood at 1002.65%, which was up 32890100.0% from 3022.64% recorded in Q2 2025.
  • In the past 5 years, Catheter Precision's EBT Margin ranged from a high of 522.66% in Q4 2023 and a low of 171925.0% during Q1 2021
  • Moreover, its 5-year median value for EBT Margin was 4291.67% (2024), whereas its average is 51202.68%.
  • In the last 5 years, Catheter Precision's EBT Margin tumbled by -1713645200bps in 2021 and then skyrocketed by 1673183300bps in 2023.
  • Over the past 5 years, Catheter Precision's EBT Margin (Quarter) stood at 165660.0% in 2021, then decreased by -2bps to 168960.0% in 2022, then soared by 100bps to 522.66% in 2023, then tumbled by -219bps to 1669.13% in 2024, then skyrocketed by 40bps to 1002.65% in 2025.
  • Its EBT Margin stands at 1002.65% for Q3 2025, versus 3022.64% for Q2 2025 and 3334.97% for Q1 2025.